Standard of Care Chemotherapy With or Without Stereotactic Body Radiation Therapy for Oligometastatic Pancreatic Cancer

Clinical trial NCT04975516 · TERMINATED

Trial details

NCT number: NCT04975516
Sponsor: Mayo Clinic
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Pancreatic Adenocarcinoma Stage IV Pancreatic Cancer AJCC v8 Recurrent Pancreatic Adenocarcinoma Oligometastatic Pancreatic Ductal Adenocarcinoma

Start date: 2023-07-18
Primary completion: 2025-11-15
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.